{
  "id": 1936122,
  "title": "Teva gets FDA priority review for Tourette syndrome therapy",
  "url": "https://urgent.news/2026/08/19/teva-gets-fda-priority-review-for-tourette-syndrome-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T12:54:08.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4634906-teva-gets-fda-priority-review-tourette-syndrome-drug?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome",
        "url": "https://urgent.news/2026/08/19/u-s-fda-accepts-tevas-new-drug-application-nda-and-grants-priority",
        "published": "2026-08-19T12:33:46.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}